https://doi.org/10.4081/aiua.2026.15826
Phenotype-associated immune-hematological profiles in men undergoing semen analysis: a real-world laboratory study
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: 24 August 2026
Published: 25 September 2026
Background: Male reproductive dysfunction reflects the interaction of endocrine, metabolic, genetic, environmental, oxidative, and immune-related factors. Although semen analysis remains the principal laboratory assessment, it is largely descriptive and provides limited insight into the systemic biological context in which semen abnormalities arise. Complete blood count (CBC)-derived inflammatory indices may offer a practical, low-cost approach to characterizing this context, but their relationship with semen-analysis phenotypes remains unclear.
Objective: To examine whether conventional haematological variables and leukocyte-derived immune-inflammatory indices differ across semen-analysis phenotypes and whether these markers are related to individual semen parameters.
Methods: This retrospective cross-sectional study analysed anonymised semen-analysis and complete blood count data from Royal Diagnostics Medical Laboratory, Riyadh, Saudi Arabia, collected between February and May 2025. The final analytical cohort comprised 245 matched records. Conventional haematological parameters, leukocyte percentages, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) were compared across the principal semen phenotypes. Correlation analyses and exploratory logistic regression models were used to assess parameter-level associations and predictive performance.
Results: Normozoospermia was the most common phenotype (49.8%), followed by asthenozoospermia (31.4%). Conventional haematological parameters were broadly comparable across phenotype groups. In contrast, neutrophil percentage (p = 0.013), lymphocyte percentage (p = 0.007), and NLR (p = 0.008) differed significantly across the principal semen phenotypes. The pattern of variation was heterogeneous rather than progressively graded across groups. PLR and SII did not differ significantly. Immune-inflammatory markers showed no meaningful correlations with sperm concentration, progressive motility, or morphology, and exploratory regression models found no independent predictive effects.
Conclusions: Leukocyte-derived inflammatory markers varied across semen-analysis phenotypes, whereas conventional haematological parameters remained broadly comparable. However, these markers showed no meaningful correlations with individual semen parameters and no independent predictive value in exploratory models. They should therefore be interpreted as descriptive indicators of immune-haematological context rather than diagnostic biomarkers of semen quality or male infertility.
Downloads
1. Agarwal A, Baskaran S, Parekh N, et al. Male infertility. Lancet. 2021; 397:319-333. DOI: https://doi.org/10.1016/S0140-6736(20)32667-2
2. Barratt CLR, Björndahl L, De Jonge CJ, et al. The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance, challenges and future research opportunities. Hum Reprod Update. 2017; 23:660-680. DOI: https://doi.org/10.1093/humupd/dmx021
3. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 6th ed. Geneva: World Health Organization; 2021.
4. Fijak M, Meinhardt A. The testis in immune privilege. Immunol Rev. 2006; 213:66-81. DOI: https://doi.org/10.1111/j.1600-065X.2006.00438.x
5. Li N, Wang T, Han D. Structural, cellular and molecular aspects of immune privilege in the testis. Front Immunol. 2012; 3:152. DOI: https://doi.org/10.3389/fimmu.2012.00152
6. Hedger MP. Immunophysiology and pathology of inflammation in the testis and epididymis. J Androl. 2011; 32:625-40. DOI: https://doi.org/10.2164/jandrol.111.012989
7. Chen Q, Deng T, Han D. Testicular immunoregulation and spermatogenesis. Semin Cell Dev Biol. 2016; 59:157-165. DOI: https://doi.org/10.1016/j.semcdb.2016.01.019
8. Aitken RJ, Baker MA. Oxidative stress and male reproductive biology. Reprod Fertil Dev. 2004; 16:581-8. DOI: https://doi.org/10.1071/RD03089
9. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health. 2014; 32:1-17. DOI: https://doi.org/10.5534/wjmh.2014.32.1.1
10. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015; 4:180-3. DOI: https://doi.org/10.1016/j.redox.2015.01.002
11. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001; 102:5-14. DOI: https://doi.org/10.1007/BF03656390
12. Forget P, Khalifa C, Defour JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017; 10:12. DOI: https://doi.org/10.1186/s13104-016-2335-5
13. Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106:dju124. DOI: https://doi.org/10.1093/jnci/dju124
14. Aykan S, Canat L, Gönültas S, et al. Are there relationships between seminal parameters and the neutrophil-to-lymphocyte ratio or the platelet-to-lymphocyte ratio? World J Mens Health. 2017; 35:51-56. DOI: https://doi.org/10.5534/wjmh.2017.35.1.51
15. Pavuluri H, Bakhtiary Z, Panner Selvam MK, Hellstrom WJG. Oxidative Stress-Associated Male Infertility: Current Diagnostic and Therapeutic Approaches. Medicina (Kaunas). 2024; 60:1008. DOI: https://doi.org/10.3390/medicina60061008
16. Bastug Y, Tokuc E, Bastug N, et al. Systemic immune-inflammation index, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are predictors of sperm presence in microdissection testicular sperm extraction. Andrologia. 2022; 54:e14419. DOI: https://doi.org/10.1111/and.14419
17. Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018; 15:369-384. DOI: https://doi.org/10.1038/s41585-018-0003-3
18. Agarwal A, Majzoub A, Parekh N, Henkel R. A Schematic Overview of the Current Status of Male Infertility Practice. World J Mens Health. 2020; 38:308-322. DOI: https://doi.org/10.5534/wjmh.190068
19. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000; 342:1887-92. DOI: https://doi.org/10.1056/NEJM200006223422507
20. Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-World Evidence - What Is It and What Can It Tell Us? N Engl J Med. 2016; DOI: https://doi.org/10.1056/NEJMsb1609216
375:2293-2297.
21. Frieden TR. Evidence for Health Decision Making - Beyond Randomized, Controlled Trials. N Engl J Med. 2017; 377:465-475. DOI: https://doi.org/10.1056/NEJMra1614394
22. Zhao S, Zhu W, Xue S, Han D. Testicular defense systems: immune privilege and innate immunity. Cell Mol Immunol. 2014; 11:428-37. DOI: https://doi.org/10.1038/cmi.2014.38
23. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002; 359:248-52. DOI: https://doi.org/10.1016/S0140-6736(02)07451-2
24. Vandenbroucke JP, Pearce N. Case-control studies: basic concepts. Int J Epidemiol. 2012; 41:1480-1489. DOI: https://doi.org/10.1093/ije/dys147
25. Hernan MA, Robins JM. Causal Inference: What If. Boca Raton: Chapman & Hall/CRC; 2020.
Supporting Agencies
Data Availability Statement
The datasets analyzed in the current study were derived from anonymized laboratory records and are not publicly available due to institutional and privacy
considerations. Reasonable requests may be considered by the corresponding author in accordance with applicable ethical and data-protection requirements.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.